Clinical Trial Update: PPAR-COMBO With Sulfonylurea [Phase 3]

View source ↗

Summary

Phase 3 trial of a PPAR-COMBO in combination with a sulfonylurea for diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• PPAR-COMBO
• Sulfonylurea (sulfonylurea)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Metabolics Diabetes Nos | Phase 3 | Status: COMPLETED